15-12G 1 mainbody.htm MAINBODY mainbody
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER
SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION
OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Commission File Number:   000-30380

DIABETEX INTERNATIONAL CORP.
(Exact name of registrant as specified in its charter)

350 Kachina Circle
Las Vegas, Nevada 89123
(702) 492-9413
(Address, including zip code and telephone number, including area code, of
registrant's principal executive offices)

COMMON STOCK, $0.002 PAR VALUE
(Title of each class of securities covered by this Form)

NONE
(Titles of all other classes of securities for which a duty to file reports
under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

Rule 12g-4(a)(1)(i)
  [  ]
Rule 12h-3(b)(1)(i)
  [  ]
Rule 12g-4(a)(1)(ii)
  [X]
Rule 12h-3(b)(1)(ii)
  [  ]
Rule 12g-4(a)(2)(i)
  [  ]
Rule 12h-3(b)(2)(i)
  [  ]
Rule 12g-4(a)(2)(ii)
  [  ]
Rule 12h-3(b)(2)(ii)
  [  ]
   
Rule 15d-6
  [  ]

Approximate number of holders of record as of the certification or notice date: 425
 


 
 

 


Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
DIABETEX INTERNATIONAL CORP.
 
 
Dated: June 27, 2005
 
By:/s/  Dr. Eugene Koppenhaver                               
             Dr. Eugene Koppenhaver, President

 

 

- 2 -